174 related articles for article (PubMed ID: 20147573)
1. A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.
Fallon P; Dursun SM
J Psychopharmacol; 2011 Jun; 25(6):755-62. PubMed ID: 20147573
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 receptors as treatment targets in schizophrenia.
Seeman P
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):56-73. PubMed ID: 20643630
[TBL] [Abstract][Full Text] [Related]
3. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
Hunt JI; Singh H; Simpson GM
J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of spontaneous dyskinesia in schizophrenia.
Fenton WS
J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.
Chouinard G; Samaha AN; Chouinard VA; Peretti CS; Kanahara N; Takase M; Iyo M
Psychother Psychosom; 2017; 86(4):189-219. PubMed ID: 28647739
[TBL] [Abstract][Full Text] [Related]
7. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.
Chouinard G; Jones BD
Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522
[TBL] [Abstract][Full Text] [Related]
9. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476
[TBL] [Abstract][Full Text] [Related]
10. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
11. Historical perspective on movement disorders.
Friedman JH
J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
[TBL] [Abstract][Full Text] [Related]
12. [The concept of supersensitivity psychosis. The particular case of clozapine].
Llorca PM; Penault F; Lançon C; Dufumier E; Vaiva G
Encephale; 1999; 25(6):638-44. PubMed ID: 10668609
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of tardive dyskinesia Part I.
Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Pires P; Villenueve
Dis Nerv Syst; 1976 Apr; 37(4):210-4. PubMed ID: 3394
[TBL] [Abstract][Full Text] [Related]
14. Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia.
Kanahara N; Kimura H; Oda Y; Ito F; Iyo M
Curr Neuropharmacol; 2021; 19(12):2214-2226. PubMed ID: 33550976
[TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia and impaired glucose tolerance.
Chong SA; Mythily ; Lum A; Huak CY; Kane J
Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
[TBL] [Abstract][Full Text] [Related]
16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
17. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
[TBL] [Abstract][Full Text] [Related]
20. Supersensitivity psychosis in a case with clozapine tolerance.
Ozcan S; Soydan A; Tamam L
Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]